Variations in the Risk of New‐Onset Diabetes Following COVID ‐19 Infection Across Body Mass Index, Deprivation, Ethnicity and Geographic Regions: Population‐Based Cohort Study in 42 Million People in England
Diabetes, Obesity and Metabolism · 2026
DOI: 10.1111/dom.70856 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Diabetes, Obesity and Metabolism, 2026. Verfasst von Sharmin Shabnam und 11 weiteren Autor:innen. Beteiligte Einrichtung: Leicester Real World Evidence Unit, Leicester Diabetes Centre, Leicester, UK. Hauptthemen laut MEDLINE: COVID-19, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health Research (NIHR) Applied Research Collaboration East Midlands (ARC EM), National Institute for Health and Care Research.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims
Evidence suggests that COVID‐19 may be associated with an increased risk of diabetes. We aimed to examine this association by investigating the role of socioeconomic and metabolic factors on the risk of new‐onset type 2 (T2D) and type 1 (T1D) diabetes after COVID‐19 diagnosis. Materials and Methods We conducted a retrospective, population‐based cohort study using linked electronic health records from NHS England's Secure Data Environment for England via the CVD‐COVID‐UK/COVID‐IMPACT consortium. Adults (≥ 18 years), alive, registered with a general practice within 1 January 2020 and 28 May 2024 were included. Exposed individuals with confirmed COVID‐19 diagnosis and no prior diabetes were matched to up to three unexposed individuals without COVID‐19 and diabetes on age, sex, region and deprivation. Flexible parametric survival models were used to estimate associations between COVID‐19 and incident diabetes by sex and across age, BMI, deprivation, ethnicity, and region.
Results
Of 50 156 810 eligible individuals, 12 859 545 with a COVID‐19 diagnosis and no prior diabetes were matched to 29 221 285 without COVID‐19; the median follow‐up was 2.4 years. Although BMI was strongly and positively associated with the risk of T2D, differences between exposed and unexposed individuals were little to none, with the excess risk concentrated in the first year (e.g., in 70‐year‐old men with BMI 35 kg/m 2 , rates were 44.2 [95% CI: 43.6–44.8] and 44.2 [43.7–44.8] per 1000 person‐years in the exposed and unexposed group, respectively, at 1 year; corresponding figures in women were 28.0 [27.6–28.5] and 29.1 [28.7–29.5]). These rate differences by COVID‐19 exposure were considerably smaller than those across BMI levels: for example, 22 more T2D cases per 1000 person‐years at 1 year for those with a BMI of 35 versus 30 kg/m 2 in unexposed 70‐year‐old men. Similarly, higher deprivation and Asian ethnicity were also more strongly associated with the risk of T2D than COVID‐19 exposure. There was no evidence of an association between COVID‐19 and T1D across all analyses.
Conclusions
In this cohort, COVID‐19 was associated with a modest, short‐term increase in T2D risk and showed no meaningful association with T1D. Established metabolic, demographic and socioeconomic factors—including age, BMI, deprivation and ethnicity—were more strongly associated with T2D incidence than COVID‐19 exposure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Leicester Real World Evidence Unit, Leicester Diabetes Centre, Leicester, UK.
- Data Analysis for Social Care and Health, Office for National Statistics, Newport, UK.
- British Heart Foundation Data Science Centre, Health Data Research UK, London, UK.
- Primary Care Research Centre, University of Southampton, Southampton, UK.
- Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
- Institute of Health Informatics, University College London, London, UK.
ORCID-Profile: Sharmin Shabnam, Genevieve Cezard, Yogini V Chudasama, Kamlesh Khunti
Förderung
- National Institute for Health Research (NIHR) Applied Research Collaboration East Midlands (ARC EM)
- National Institute for Health and Care Research
Zitieren
APA
Shabnam, S., Razieh, C., Nolan, J., Islam, N., Cezard, G., Chudasama, Y. V., Gillies, C. L., Banerjee, A., Wood, A., Khunti, K., Zaccardi, F., & CVD‐COVID‐UK/COVID‐IMPACT Consortium (2026). Variations in the Risk of New‐Onset Diabetes Following COVID ‐19 Infection Across Body Mass Index, Deprivation, Ethnicity and Geographic Regions: Population‐Based Cohort Study in 42 Million People in England. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.70856
Vancouver
Shabnam S, Razieh C, Nolan J, Islam N, Cezard G, Chudasama YV, et al. Variations in the Risk of New‐Onset Diabetes Following COVID ‐19 Infection Across Body Mass Index, Deprivation, Ethnicity and Geographic Regions: Population‐Based Cohort Study in 42 Million People in England. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.70856
BibTeX
@article{Shabnam2026,
author = {Shabnam, Sharmin and Razieh, Cameron and Nolan, John and Islam, Nazrul and Cezard, Genevieve and Chudasama, Yogini V and Gillies, Clare L and Banerjee, Amitava and Wood, Angela and Khunti, Kamlesh and Zaccardi, Francesco and CVD‐COVID‐UK/COVID‐IMPACT Consortium, CVD‐COVID‐UK/COVID‐IMPACT Consortium},
title = {Variations in the Risk of New‐Onset Diabetes Following COVID ‐19 Infection Across Body Mass Index, Deprivation, Ethnicity and Geographic Regions: Population‐Based Cohort Study in 42 Million People in England},
journal = {Diabetes, Obesity and Metabolism},
year = {2026},
doi = {10.1111/dom.70856}
}
EUVIMED